LabCorp developing options to prioritize COVID-19 testing for inpatient population
On Mar. 23, 2020, LabCorp announced that it was exploring all options to prioritize COVID-19 testing for the…
-
-
BioReference Laboratories and City of Detroit provide testing for Coronavirus disease 2019
On Mar. 23, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the City of Detroit…
-
Soligenix and University of Hawaii at Manoa initiate work on novel Coronavirus vaccine for COVID-19
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…
-
CSL Group to help battle Coronavirus
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
-
Mount Sinai developing an ‘end-to-end’ diagnostics solution for COVID-19
On Mar. 23, 2020, an expert team of researchers and clinicians in microbiology, virology, pathology, molecular science, and…
-
Resverlogix clinical candidate apabetalone featured as potential COVID-19 treatment in publication
On Mar. 23, 2020, Resverlogix announced a bioRxiv publication that has shown apabetalone to inhibit specialized proteins –…
-
Philips ramped up production of critical health technology products in response to COVID-19 pandemic
On Mar. 22, 2020, Royal Philips announced that it is increasing the production of certain critical care products and…
-
Quest Diagnostics dedicated special hours for non-COVID-19 testing for older and Highly vulnerable patients
On Mar. 21, 2020, through its “Peace of Mind” program, Quest Diagnostics took extra measures to ensure individuals…
-
NIH shifted non-mission-critical laboratory operations to minimal maintenance phase
On Mar. 20, 2020, to further reduce the risk of transmission of COVID-19 and enhance the safety of…
-
BioReference Laboratories and State of New Jersey provided testing for Coronavirus 2019
On Mar. 20, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the State of New…
-
Amneal Accelerates Distribution and Production of Hydroxychloroquine Sulfate to Meet Potential Needs of COVID-19 Patients Nationwide
On Mar. 20, 2020, Amneal Pharmaceuticals, one of the largest U.S.-based generics manufacturers, announced that it is responding to…
-
New study expanded understanding of influenza-associated complications
On Mar. 20, 2020, a study was published in JAMA that expands the understanding of influenza-associated complications. Influenza…
-
Cardax releases white paper on the potential role of Astaxanthin in treatment of Coronavirus disease
On Mar. 20, 2020, Cardax released a white paper outlining the potential role of astaxanthin in the treatment…
-
3M outlined actions to support healthcare effort to combat COVID-19
On Mar. 20, 2020, 3M announced it had doubled its global output of N95 respirators to an annual…
-
PRA Health Sciences launches COVID-19 monitoring program
On Mar. 20, 2020, PRA Health Sciences announced the commercial availability of the COVID-19 Monitoring Program, a mobile…
-
FDA granted Bellerophon emergency expanded access for INOpulse for treatment of COVID-19 virus
On Mar. 20, 2020, Bellerophon Therapeutics announced the U.S. Food and Drug Administration (FDA) had granted emergency expanded…
-
Amneal accelerated distribution and production of hydroxychloroquine sulfate to meet potential needs of COVID-19 patients
On Mar. 20, 2020, Amneal Pharma announced that it was responding to the national COVID-19 health emergency by…
-
Chembio Diagnostics received $4 million purchase order from Bio-Manguinhos for production of DPP COVID-19 IgM/IgG system in Brazil
On Mar. 20, 2020, Chembio Diagnostics announced receipt of a $4 million order from Bio-Manguinhos for the purchase…
-
Biotechnology | COVID-19 | Disease | Infectious Disease | Medicine | Non-Profit Research | Therapeutics
University of Pennsylvania $1.5 billion Hospital Pavilion construction allowed to continue
On Mar. 20, 2020, the University of Pennsylvania announced that Pavilion project construction would be allowed to continue…
-
GM and Ventec Life Systems announced joint cross-sector ventilator production program
On Mar. 20, 2020, GM and Ventec Life Systems announced they were collaborating to enable Ventec to increase…
-
Adaptive Biotechnologies and Microsoft expanded partnership to decode COVID-19 immune response and provide open data access
On Mar. 20, 2020, Adaptive Biotechnologies and Microsoft announced they were leveraging their existing partnership mapping population-wide adaptive…
-
Roche initiated phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia
On Mar. 19, 2020, Roche announced it was working with the U.S. Food & Drug Administration (FDA) to…
-
UArizona Cancer Center received $69M grant forsSkin cancer prevention study
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
-
FDA approved Epclusa (Sofosbuvir/Velpatasvir) for children with Chronic Hepatitis C infection
On Mar. 19, 2020, Gilead Sciences announced the U.S. Food and Drug Administration (FDA) had approved a supplemental…
-
High-speed microscope captured fleeting brain signals
On Mar. 19, 2020, University of California, Berkeley, investigators have now built such a camera: a microscope that…
-
Cumberland Pharmaceuticals announced initiative to expand availability of Caldolor to treat fevers associated with Coronavirus Infections
On Apr. 1, 2020, Cumberland Pharma announced a national initiative to support hospitals and clinics that use Caldolor…
-
Mesa Biotech received funding from HHS for development of a 30 minute molecular point-of-care SARS-CoV-2 test
On Mar. 19, 2020, Mesa Biotech announced it has significantly expanded its capacity to test clinical samples for…
-
LabCorp sets dedicated hours to serve the non-COVID-19 testing needs for elderly and most vulnerable people
On Mar. 19, 2020, LabCorp announced it is dedicating the first hour of service each day at its…
-
Teva donated potential COVID-19 treatment, hydroxychloroquine sulfate tablets to hospitals nationwide
On Mar. 19, 2020, Teva announced the immediate donation of more than 6 million doses of hydroxychloroquine sulfate…
-
iBio announced development of proprietary COVID-19 vaccine candidates
On Mar. 19, 2020, iBio announced its progress towards developing vaccine candidates for preventing infection from the SARS-CoV-2…
